ITI News Archive
Stanford Medicine News
Immune deviations seen in severe COVID-19 cases
A Stanford study shows that in severely ill COVID-19 patients, “first-responder” immune cells, which should react immediately to signs of viruses or bacteria in the body, instead respond sluggishly.
Vaping linked to higher COVID-19 risk
Data collected in May shows that teenagers and young adults who vape face a much higher risk of COVID-19 than their peers who do not vape, Stanford researchers found.
Stanford can begin pooled testing for COVID-19
A Stanford Medicine test for the coronavirus has been validated for pooled testing. This method greatly increases testing capacity and conserves testing resources, which continue to be in short supply.
How pathogens put the brakes on immune response
Researchers at the Stanford School of Medicine have discovered that cells infected by viruses or bacteria send out a “don’t eat me” signal to avoid attack by the body’s immune system.
Anthony Fauci talks COVID-19 with dean
The nation’s top infectious disease expert spoke with School of Medicine Dean Lloyd Minor about the challenges posed by COVID-19, the hope for emerging vaccines and treatments, and what’s still unknown about the virus.
Study to look at oral drug for COVID-19
Researchers want to determine whether favipiravir, an oral drug, is effective in reducing the severity of symptoms and shortening the duration of COVID-19.
Scientists contribute to WHO mask guidelines
Scientists say we should wear masks to control the spread of COVID-19. Stanford experts share the evidence that informed the World Health Organization’s recommendations.
Self-swabbing tests for COVID-19 accurate
People can be taught to do their own nasal swabs for accurate COVID-19 testing, limiting the exposure of health care workers and the use of protective equipment, according to Stanford researchers.
$1.49 million for inflammation research
The Chan Zuckerberg Initiative has awarded $1.49 million to research projects involving Stanford Medicine scientists who will investigate emerging ideas about the role of inflammation in disease.
COVID-19 drug for outpatients tested
Scientists at Stanford Medicine are investigating whether a molecule called interferon-lambda can help people with mild cases of COVID-19 feel better and reduce their transmission of the disease-causing virus.